Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity.
about
Mechanism of Platinum Derivatives Induced Kidney InjuryMechanisms of Cisplatin nephrotoxicityAn integrated view of cisplatin-induced nephrotoxicity and ototoxicityEndoplasmic reticulum stress stimulates p53 expression through NF-κB activationMultiple actions of pifithrin-alpha on doxorubicin-induced apoptosis in rat myoblastic H9c2 cellsAutophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injuryCellular and Molecular Mechanisms of AKI.Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacyProtection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection.p53 regulates renal expression of HIF-1{alpha} and pVHL under physiological conditions and after ischemia-reperfusion injuryAugmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment.The role of Bcl-x(L) protein in nucleotide excision repair-facilitated cell protection against cisplatin-induced apoptosis.Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells.Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation.Pathologies associated with the p53 response.Pathophysiology of cisplatin-induced acute kidney injury.MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival.Epigallocatechin-3-gallate protects against cisplatin nephrotoxicity by inhibiting the apoptosis in mouse.Multiple analytical approaches demonstrate a complex relationship of genetic and nongenetic factors with cisplatin- and carboplatin-induced nephrotoxicity in lung cancer patientsTubular p53 regulates multiple genes to mediate AKITaurine and the renal systemFragmented mitochondria are sensitized to Bax insertion and activation during apoptosis.Hyperglycemia, p53, and mitochondrial pathway of apoptosis are involved in the susceptibility of diabetic models to ischemic acute kidney injury.mTOR contributes to ER stress and associated apoptosis in renal tubular cellsInhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancerThe p53 inhibitor pifithrin-α can stimulate fibrosis in a rat model of ischemic acute kidney injury.Utilisation of nanoparticle technology in cancer chemoresistance.MicroRNA-7 Compromises p53 Protein-dependent Apoptosis by Controlling the Expression of the Chromatin Remodeling Factor SMARCD1.A Comprehensive Review on the Genetic Regulation of Cisplatin-induced NephrotoxicityThe copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity.Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway.Functional TauT protects against acute kidney injury.Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity.Neuropeptide Y protects kidney against cisplatin-induced nephrotoxicity by regulating p53-dependent apoptosis pathway.Activation and involvement of p53 in cisplatin-induced nephrotoxicity.p53 activates miR-192-5p to mediate vancomycin induced AKIEpicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.Murine cytomegalovirus infection and apoptosis in organotypic retinal cultures.Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update.Role of p53 in Anticancer Drug Treatment- and Radiation-Induced Injury in Normal Small Intestine.
P2860
Q26783436-F1AF0D27-EF41-42D6-9815-21246CBB5644Q26996320-2BAAABEC-EB00-42E6-9DF2-2B973FF8DBDFQ28080615-E1A8DB79-BAE3-42C6-95B0-7129BC1F6E35Q28481673-D11BF7AD-CE37-4EFD-BB3A-0D3806871A6AQ28577227-1F46A3EC-A296-4BA4-8F14-0DF8E0914247Q28579843-E85BAAC5-1A66-4B08-B23F-B50DDC560382Q30277374-FC700728-1F25-48AB-B9A1-DAFBC39280E3Q30366115-205FA16A-7ED3-4A7E-AE5B-6679873442FEQ30390165-3D4CFF6B-EEAC-4B90-ABDF-9F53C3D326A2Q30485066-20F51ABA-D971-4CF1-B773-F854DD3DB38AQ30669518-4B1ACC35-4428-4079-A124-06920A389578Q33421515-16ACFD12-F042-4960-83A0-65FC36CD0D49Q33655696-3012E928-7CC5-480E-9060-096F566309B1Q33808489-29F78AB2-5E82-4119-8370-55AA6C6E4C36Q33931980-FAA42A21-ACE4-4D1F-90E3-E9C868A05724Q34073302-8A1D39E7-3CBA-49AB-9216-EBEDD12A4956Q34112716-44275FE0-D781-4E14-8FB6-007A9D0143B8Q34121293-D7A3FE72-9662-48CD-B76D-DA0B2624A1D0Q34177673-3511E4A8-EA64-404A-9AD4-CFBF60F6D548Q34260039-412F1403-E529-4912-85D4-CF061CF6C5BDQ34364243-480B47DB-7A01-46F9-AEE2-CB2189DE150FQ34718003-5950AD36-8DE9-449E-9EC7-FCCB84024376Q34774010-699C6332-194E-4654-913A-37E7B488E3C2Q35035259-FB893943-8115-4E06-82EB-BBA6E20F522EQ35572426-0A03BC60-8257-4ABC-A1BF-F9F1C1590068Q35924490-E4A84379-2A42-4204-822D-B6D6A6670DF2Q36421258-66582A1B-2304-472E-99BA-85A42A019730Q36489308-1B05F7FD-8994-4B47-9665-D2F8BA122842Q36906569-A2C50397-E828-40DE-9F63-B0B73BEB3E40Q37138812-77359738-7CFB-434C-9302-9C975DC9EEB7Q37190275-44C84F71-45FA-4775-B478-DB79AE6F7B4EQ37211158-B97FE850-CA48-4FBD-B120-7995CAF7AC9DQ37259459-F2BD97D3-112E-4A79-8120-875EAF0A24B9Q37351157-222B89B8-895E-4B6D-8D4A-A4D785E56827Q37473362-EADE44AA-0142-4E03-B863-071B4C26E6D8Q37493860-C0BEC505-F982-43AB-BEFD-38A65881BC3AQ37592492-43DF0B70-7E37-4FE1-9856-085E90D30196Q37661144-7D063591-029E-4ED7-B44A-937A5131E28BQ37989844-1F01149D-11B0-4635-891D-62DEC35F9FCAQ38108321-8DDB06D4-2B8E-4DA4-99F1-D326C8B3D2A5
P2860
Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Role of p53 in cisplatin-induc ...... p53 transcriptional activity.
@en
type
label
Role of p53 in cisplatin-induc ...... p53 transcriptional activity.
@en
prefLabel
Role of p53 in cisplatin-induc ...... p53 transcriptional activity.
@en
P2093
P2860
P1476
Role of p53 in cisplatin-induc ...... p53 transcriptional activity.
@en
P2093
Cong-Yi Wang
Stephen Hsu
Xiaolan Yi
Zheng Dong
P2860
P304
P356
10.1152/AJPRENAL.00262.2004
P577
2004-08-17T00:00:00Z